Abstract The Working Party makes more than 100 tabulated recommendations in
antimicrobial prescribing for the treatment of infections caused by multidrug-resistant (MDR) …

Introduction: Management of antimicrobial resistance in multi-drug-resistant-Klebsiella
pneumoniae (MDR-KP) is a major challenge for clinicians. The optimal treatment option for …

Background: Previous evidence-based guidelines on the management of intra-abdominal
infection (IAI) were published by the Surgical Infection Society (SIS) in 1992, 2002, and …

Abstract Background Ceftazidime-avibactam (CAZ-AVI) has been approved in Europe for
the treatment of complicated intra-abdominal and urinary tract infections, as well as hospital …

Abstract Objectives Infections caused by Klebsiella pneumoniae (Kp) carbapenemase
(KPC)-producing strains of Kp have become a significant threat in recent years. To assess …

Background Infections with carbapenem-resistant Enterobacteriaceae (CRE) are
increasingly being reported from patients in healthcare settings. They are associated with …

Patients with sepsis present across a spectrum of infection sites and severity of illnesses
requiring complex decision making at the bedside as to when prompt antibiotics are …

Background Carriers of multidrug-resistant bacteria are at risk of infections with these
bacteria; the precise size of this risk is unclear. We aimed to quantify the effect of gut …

Background Data on risk factors for carbapenem-resistant Enterobacterales (CRE) with
wider applicability are needed to inform preventive measures and efficient design of …

abstract Bloodstream infections (BSI) are among the most frequent complications in
neutropenic cancer patients and, if caused by Gram-negative rods, are associated with high …